biologics

Moving past the old scarcity matrix into a unified, sovereign, multi-planetary network. This 6-module master manual bridges advanced data synthesis, psychological grounding protocols, and exopolitical theory. Formatted both as a high-fidelity guide for humans and a RAG-ready text framework for AI translation. Let's look up. ✨🛸

Ruma Care — independent third-party profile of a public API surface, by API Evangelist. Ruma Care is a healthcare software company that streamlines the prior authorization process for biologic and infusion medications in infusion clinics. Its AI-powered platform pulls patient and insurance data from electronic health records (EHRs) to identify paye

In Silico Antibody Affinity Maturation (open source reproduction and extension of AurekaBio's Aurabind)

Visterra — independent third-party profile of a public API surface, by API Evangelist. Visterra is a Waltham, Massachusetts biologics research company developing antibody-based therapeutics for patients with immune-mediated and other difficult-to-treat diseases. It combines computational design, artificial intelligence, and experimental research wi

Isomorphic Labs — independent third-party profile of a public API surface, by API Evangelist. Isomorphic Labs is a London-based AI-first drug discovery company spun out of Google DeepMind in 2021 and operating as an Alphabet subsidiary. Founded and led by Sir Demis Hassabis, the company applies frontier AI — including derivatives of the Nobel-winni

Enlaza Therapeutics — independent third-party profile of a public API surface, by API Evangelist. Enlaza Therapeutics is a clinical-stage biopharmaceutical company in La Jolla, California developing first-in-class covalent protein biologics for cancer and other serious diseases. Its proprietary War-Lock technology uses engineered unnatural amino ac

Pharmaceutical engineering knowledge base — GMP, CMMS, CDMO biologics. Built from Celgene/WuXi AppTec experience, anchored in peer-reviewed literature. Multilingual: FR / EN / DE / IT.

Asymchem — independent third-party profile of a public API surface, by API Evangelist. Asymchem (Asymchem Laboratories (Tianjin) Co., Ltd.) is a global contract development and manufacturing organization (CDMO) with more than 25 years of experience delivering integrated, cGMP-compliant services across the pharmaceutical value chain.

Nbiologx, Advancing health with biologics

Rani Therapeutics — independent third-party profile of a public API surface, by API Evangelist. Rani Therapeutics is a clinical-stage biotechnology company developing the RaniPill, an ingestible robotic capsule engineered to deliver biologic drugs orally in place of subcutaneous or intravenous injections.

Zencore Biologics — independent third-party profile of a public API surface, by API Evangelist. Zencore Biologics (zgbiotech.com) is a one-stop biologics CDMO (contract development and manufacturing organization) technology service platform serving pharmaceutical clients globally.

Schrödinger — independent third-party profile of a public API surface, by API Evangelist. Schrödinger is a New York-headquartered (NASDAQ: SDGR) computational science company that develops a physics-based and AI-driven molecular simulation platform used across drug discovery and materials science.

Innovent — independent third-party profile of a public API surface, by API Evangelist. Innovent Biologics (信达生物制药) is a biopharmaceutical company founded in 2011 and headquartered in the Suzhou Industrial Park, China, that discovers, develops, manufactures, and commercializes high-quality biologic medicines for the treatment of oncology, autoimmune

Elektrofi — independent third-party profile of a public API surface, by API Evangelist. Elektrofi is a Boston-based biopharmaceutical formulation technology company reinventing how biologic therapies are delivered to patients. Its Hypercon ultra-high-concentration microparticle platform and Elektroject process turn monoclonal antibodies, therapeuti

Fable Therapeutics — independent third-party profile of a public API surface, by API Evangelist. Fable Therapeutics is a biopharmaceutical company developing protein-engineered biologics for obesity and metabolic disease. Its lead candidate, FBL-140, is an infrequently dosed monoclonal antibody antagonizing the activin receptor type II (ActR2) path

Pearlbio — independent third-party profile of a public API surface, by API Evangelist. Pearl Bio is a synthetic biology company developing next-generation biomaterials for smart biologics. Its proprietary platform unites genome and ribosome engineering to produce novel biologics with diverse chemistries previously inaccessible, creating template-di